Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Consolidated Net Profit

    Back to Income Statement
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹30 Cr₹27 Cr₹15 Cr₹10 Cr₹7.37 Cr

What is the latest Consolidated Net Profit of KILITCH DRUGS (INDIA) ?

The latest Consolidated Net Profit ratio of KILITCH DRUGS (INDIA) is ₹30 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹30 Cr
Mar2025₹27 Cr
Mar2024₹15 Cr
Mar2023₹10 Cr
Mar2022₹7.37 Cr

How is Consolidated Net Profit of KILITCH DRUGS (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹30 Cr
12.98
Mar2025 ₹27 Cr
82.87
Mar2024 ₹15 Cr
39.75
Mar2023 ₹10 Cr
41.82
Mar2022 ₹7.37 Cr -

Compare Consolidated Net Profit of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹654.2 Cr 1.9% -5.4% 2.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -1.8% -3.7% 17.2% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 3.4% 10.1% 57.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.6% 0.8% 37.8% Stock Analytics
CIPLA ₹110,273.0 Cr -0.4% -5.6% -11.9% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr -1.1% -4.9% -9.9% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

1.9%

-5.4%

2.6%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses